Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDAer Resigns Over Plan B; Senators Seek Results Of GAO Investigation

This article was originally published in The Tan Sheet

Executive Summary

FDA Office of Women's Health Director Susan Wood is resigning over the agency's handling of Barr Labs' application to switch its Plan B emergency contraceptive over-the-counter

You may also be interested in...



FDA Sidelines Chief Spokesperson As It Grapples With Fallout From COVID-19 Plasma Authorization

Emily Miller, who joined FDA a few days before its controversial roll out of emergency use authorization for convalescent plasma, remains at the agency. Situation shows importance of sticking to science-based decisions, former FDA officials say.

People In Brief

NPA’s former exec director joins CHPA; Henderson heads FDA’s women’s health office on permanent basis; Nestle promotes nutrition exec Goodyear; Bayer vet Lowinski leads Sanofi’s Asia region; more People In Brief.

People In Brief

NPA’s former exec director joins CHPA; Henderson heads FDA’s women’s health office on permanent basis; Nestle promotes nutrition exec Goodyear; Bayer vet Lowinski leads Sanofi’s Asia region; more People In Brief.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS098601

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel